Nanomedicine-based multimodal therapies: Recent progress and perspectives in colon cancer

Area of Science:

• Oncology
• Nanotechnology
• Biomedical Engineering

Background:

• Colon cancer incidence is rising, with conventional chemotherapy showing limitations due to poor targeting and side effects.
• Nanomedicines demonstrate potential for colon cancer therapy through enhanced permeability and retention (EPR) effect, leading to tumor site accumulation.
• Multimodal nanomedicine strategies offer synergistic therapeutic benefits for colon cancer treatment.

Purpose of the Study:

• To review recent advances in nanomedicine-based therapeutic strategies for colon cancer.
• To discuss the mechanisms, limitations, and future directions of various nanotherapies.
• To highlight the potential of nanomedicines in improving colon cancer treatment outcomes.

Main Methods:

• Literature review of nanomedicine applications in colon cancer therapy.
• Analysis of multimodal therapeutic strategies including chemotherapy, radiotherapy, phototherapy, chemodynamic therapy, gas therapy, and immunotherapy.
• Discussion of therapeutic mechanisms, limitations, and improvements.

Main Results:

• Nanomedicines enable enhanced drug delivery and accumulation at colon tumor sites.
• Multimodal strategies combining different therapies show synergistic effects.
• Various nanomedicine approaches, including phototherapy and immunotherapy, are advancing colon cancer treatment.

Conclusions:

• Nanomedicines represent a significant advancement in colon cancer therapy, offering targeted and multimodal treatment options.
• Further research into nanomedicine mechanisms and clinical translation is crucial for overcoming current limitations.
• The future of colon cancer treatment is likely to involve sophisticated nanomedicine-based approaches.